Annemarie Larkin

Annemarie Larkin serves as a Principal Investigator at Atlantic Technological University in Ireland within the Department of Life Sciences, where she leads the Cellular Health & Toxicology Group. Her research spans multiple areas of cancer biology with a particular focus on molecular mechanisms of cancer progression and drug resistance.

Dr. Larkin's research interests center on cancer biology, particularly pancreatic cancer and melanoma. Her work explores drug resistance mechanisms, with significant contributions to understanding Multidrug Resistance Protein 1 and P-Glycoprotein. She also investigates monoclonal antibody development for diagnostic applications and studies neoplastic cell lines to understand cancer cell behavior. Her fingerprint analysis reveals strong activity in Pharmacology, Toxicology, Immunology, and Microbiology domains.

Her publication record demonstrates expertise in cancer genomics, with recent work focusing on pancreatic cancer organoid modeling, melanoma biomarkers, and fungal diagnostic applications. The research shows consistent activity with publications spanning from 1997 to 2022, with multiple high-impact papers in the last three years.

• Scientific Awards: No specific awards mentioned in available information

Dr. Larkin maintains active collaborations across multiple institutions, particularly in cancer research projects. Her work with pancreatic cancer organoids and melanoma biomarkers demonstrates translational research with potential clinical applications. The Cellular Health & Toxicology Group she leads appears to focus on molecular mechanisms of cellular responses to various stressors and therapeutic agents.